Search

Your search keyword '"Schrooten, Yoeri"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Schrooten, Yoeri" Remove constraint Author: "Schrooten, Yoeri"
45 results on '"Schrooten, Yoeri"'

Search Results

1. Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort

2. Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length Genomes

5. Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba

6. High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba

7. Lessons in Developing a Full-Genome Next-Generation Sequencing Pipeline for Molecular Epidemiology of Hcv

9. Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001

14. Additional file 3: Figure S1. of Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy

15. Additional file 4: Table S2. of Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy

16. Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy

18. Current levels of drug resistance among therapy-Native HIV infected patients have significant impact on treatment response

19. Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba

20. Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

21. High frequency of antiviral drug resistance and non-b subtypes in HIV-1 patients failing antiviral therapy in Cuba

22. Trends and Predictors of Transmitted Drug Resistance (TDR) and Clusters with TDR in a Local Belgian HIV-1 Epidemic

24. Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.

25. Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006

26. Characterization of in vivo mutational patterns within HIV-1 group M viruses developed during long-term enfuvirtide therapy and after discontinuation on enfuvirtide

27. Prevalence of Transmitted Resistance in Newly Diagnosed HIV-Infected Individuals in Belgium Prospectively Collected Frim 2003 to 2005 is Significantly Higher Than 5%

28. Prospective Collection of Data on the Prevalence of Transmitted Resistance in Newly Diagnosed HIV-Infected Individuals in Belgium in 2004

29. Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response [1]

30. Performance of the VERSANT® HIV-1 Resistance Assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes

31. HIV-1 resistance testing using a commercial kit can be performed reliably without prior sequencing experience

32. Drug resistance among therapy-naïve HIV-infected patients studied by sequencing and VERSANT HIV-1 resistance assays (LiPA) has limited impact on treatment response

35. Prevalence and Epidemiology of HIV Type 1 Drug Resistance among Newly Diagnosed Therapy-Naive Patients in Belgium from 2003 to 2006

38. Performance of the VERSANT®HIV-1 Resistance Assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes

39. A Combination of Poor Adherence and a Low Baseline Susceptibility Score is Highly Predictive for HAART Failure

40. Performance of the VERSANT® HIV-1 Resistance Assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes

41. Additional file 1: Table S1. of Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy

42. Additional file 1: Table S1. of Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy

45. Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Catalog

Books, media, physical & digital resources